The Effect of Healthy Nutrition and Yoga Program on Obese Children
Launched by TC ERCIYES UNIVERSITY · Feb 16, 2024
Trial Information
Current as of September 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The prevalence of childhood obesity as a chronic disease is rapidly increasing all over the world, including low- and middle-income countries. Literature highlights that approximately 40.1 million children worldwide are overweight and, at the same time, overweight and obesity are rapidly increasing in almost every country in the world with no signs of slowing down. According to data, it is reported that the prevalence of overweight and obesity among children has increased from 4% to 18% in the last 41 years, and the number of obese school-age children has increased from 11 million to 124 mi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The child's body mass index is at the 85th percentile and above according to age and gender,
- • Do not have any chronic disease that may cause obesity (diabetes mellitus, hypothyroidism, etc.).
- • No neurodevelopmental delay,
- • Those who agree to participate in the study after they and their parents are informed in detail about the study will be included in the study.
- Exclusion Criteria:
- • Children who fall outside the inclusion criteria will not take part in the research.
About Tc Erciyes University
TC Erciyes University is a leading academic institution in Turkey, dedicated to advancing medical research and healthcare through innovative clinical trials. With a strong emphasis on scientific excellence and collaboration, the university leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies aimed at improving patient outcomes. Committed to ethical standards and regulatory compliance, TC Erciyes University fosters a research environment that promotes the development of new therapies and interventions, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karaman, Turkey
Patients applied
Trial Officials
Dilara Şahin, MSc
Principal Investigator
Erciyes University Health Sciences Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported